RXRX - Cathie Wood Is Buying This Under-the-Radar AI Stock
2024-05-12 08:15:00 ET
Many famous names on Wall Street are rapidly scooping up shares of the most prominent artificial intelligence (AI) companies, including Nvidia and Alphabet , among other tech giants. Though these market leaders are attracting most of the AI-centered attention, there are smaller players in the field, such as Recursion Pharmaceuticals (NASDAQ: RXRX) .
This mid-cap biotech uses AI in an innovative way (more on that below). It has attracted the attention of a notable player on the street: Cathie Wood, CEO of Ark Invest. Let's see what makes this stock intriguing.
Ark Invest seeks out disruptive technologies that are shaping the future. One of their actively managed exchange-traded funds (ETFs), ARK Genomic Revolution , targets companies trying to improve the quality of life through scientific innovation.
For further details see:
Cathie Wood Is Buying This Under-the-Radar AI Stock